您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股财报]:德康医疗 2026年季度报告 - 发现报告

德康医疗 2026年季度报告

2026-04-30 美股财报 车伟光
报告封面

SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 (I.R.S. Employer Identification No.) 92121(Zip Code) (Address of principal executive offices) (858)200-0200 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and(2)has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Non-accelerated filer☐ Acceleratedfiler☐Smallerreportingcompany☐Emerging growthcompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ As ofApril23, 2026, there were385,872,977 shares of the registrant’s common stock outstanding. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Except for historical financial information contained herein, the matters discussed in this Quarterly Report on Form 10-Q maybe considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or theSecurities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and subject to thesafe harbor created by the Private Securities Litigation Reform Act of 1995. Such statements include declarations regarding ouroperations, financial condition and prospects, and business strategies, and are based on management’s intent, beliefs,expectations, and assumptions as of the date of this report. Investors are cautioned that any such forward-looking statementsare not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which arebeyond our control. Actual results could differ materially from those indicated or implied by such forward-looking statements.Important factors that could cause actual results to differ materially from those indicated by such forward-looking statementsinclude, but are not limited to: (i) that the information is of a preliminary nature and may be subject to further adjustment; (ii)those risks and uncertainties identified under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year endedDecember31, 2025 filed with the Securities and Exchange Commission, or the SEC, on February12, 2026, together with anyupdates identified under “Risk Factors” in our subsequently filed Quarterly Reports on Form 10-Q; and (iii) the other risksdetailed from time-to-time in our other reports and registration statements filed with the SEC. Except as required by law, weundertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information,future events or otherwise. AVAILABLE INFORMATION Our website address is located at www.dexcom.com and our investor relations website is located at investors.dexcom.com. Wefile electronically with the SEC our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form8-K, and other reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. We make available on ourwebsite, free of charge, copies of these reports and other information as soon as reasonably practicable after we electronicallyfile such material with, or furnish it to, the SEC. Information that is based on estimates, forecasts, projections, market researchor similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially fromevents and circumstances reflected in this information. Unless otherwise expressly stated, we obtained industry, business,market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and otherthird parties, industry, medical and general publications, government data, and similar sources. We announce material information to the public about us, our pro